TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SAMPLE TO OUTCOME

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

SAMPLE TO OUTCOME

ST13

US500000079264602

Class

9, 10

Filing

79264602

Registration

6087728

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

07/01/2025

Classification

Registered

Trademark type

Word

Nice classes

9, 10

Filing date

05/21/2019

Registration date

06/30/2020

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/30/2020

Last transaction

07/01/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

16

Owner location

DE

Examiner

GUROK, GALINA

Law office

N80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Qiagen GmbH

Representatives

Keith A. Weltsch Scully, Scott, Murphy & Presser, P.C.

Technical classification

Nice Classes

Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Downloadable and recorded computer software for data and document management, medical teaching; downloadable and recorded computer software and related databases for use in preparing and managing nucleic acid and protein assay analysis and for managing quality control, validation, interpretation, reporting, clinical decision support, data management, integration with medical records, physician portals, laboratory networking, professional healthcare and trial matching services all related to molecular and genomic analysis; downloadable and recorded computer software, namely, evidence-based decision support software used as an aid in the interpretation of variants observed in genomic sequencing data; downloadable and recorded computer software for evaluation of genomic variants in the context of software for searching and allocating published biomedical literature, professional association guidelines, publicly available databases and annotations, drug labels, and/or clinical-trials; downloadable and recorded computer software for preparing, interpretation and managing of bioinformatics analyses, optionally combined with data management, graphical viewing and output options; downloadable and recorded computer programs and software for biological data mining; downloadable and recorded computer programs and software for developing bioinformatics database for others; bio-chips for research or scientific purposes; DNA-chips; RNA-chips; next-generation sequencing (NGS) data processor; bioinformatics data processor; computer hardware and downloadable and recorded computer software for collecting, storing, analyzing, visualizing, and interpreting bioinformatics, genomics, and phenomics data sets; computer hardware and downloadable and recorded computer software for the monitoring of pathogens; downloadable computer databases for bioinformatics, genomics, phenomics, microbiome, metagenomics, organism-and -pathogen-specific genotype records, and organism and pathogen-specific phenotype information; downloadable and recorded computer software for use in the integration, analysis and visualization of biomedically relevant information allowing users to explore compound, target, assay, biological pathway and disease information; downloadable and recorded computer software and databases for the analysis of genomes, exomes, targeted amplicons, transcriptomes, and epigenetic NGS sequencing data; downloadable and recorded computer software, software development tools, and visualization software modules, for analysis, discovery, verification, and validation of disease biomarkers

Class 10

Medical diagnostic testing instruments for processing and analysis of genetic samples primarily for single-cell genomic, transcriptomic, or proteomic analysis; medical and diagnostic apparatus for testing DNA and RNA samples, using gene expression tests, gene expression profiling assays, genetic information and data, protein biomarkers, clinical data, and/or demographic information; testing apparatus for medical purposes for testing DNA and RNA samples sold as a unit with downloadable bioinformatics and machine learning algorithm software and medical data software to support treatment decisions; medical testing apparatus for testing DNA and RNA samples and quantifying biomarker levels and relative expression of host response genes; medical apparatus and instruments for detecting tumor cancer, heredity and genetic diseases; medical testing apparatus for samples of body fluids, tissue and organs; genome machine for medical purposes, namely, apparatus for DNA and RNA medical testing; diagnostic apparatus for the detection of cancer, genetic or heredity diseases

Publications

History of USPTO decisions and trademark events.

22 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

06/30/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/10/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/24/2020

FIMP

FINAL DISPOSITION PROCESSED

10/23/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/30/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

06/30/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/14/2020

PUBO

PUBLISHED FOR OPPOSITION

04/14/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/25/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/11/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/05/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/04/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/04/2020

RFNT

REFUSAL PROCESSED BY IB

09/20/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/04/2019

RFRR

REFUSAL PROCESSED BY MPU

09/04/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/21/2019

CNRT

NON-FINAL ACTION WRITTEN

08/20/2019

MAFR

APPLICATION FILING RECEIPT MAILED

08/20/2019

DOCK

ASSIGNED TO EXAMINER

08/16/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/16/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/08/2019

Continuous trademark protection

Get notified about every new filing that threatens SAMPLE TO OUTCOME or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.